Dymond, A. W., So, K., Martin, P., Huang, Y., Severin, P., Mathews, D., . . . Mariani, G. (2016). Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: Results from two clinical trials. Eur J Clin Pharmacol.
Citação norma ChicagoDymond, Angela W., Karen So, Paul Martin, Yifan Huang, Paul Severin, David Mathews, Eleanor Lisbon, and Gabriella Mariani. "Effects of Cytochrome P450 (CYP3A4 and CYP2C19) Inhibition and Induction On the Exposure of Selumetinib, a MEK1/2 Inhibitor, in Healthy Subjects: Results From Two Clinical Trials." Eur J Clin Pharmacol 2016.
MLA citiranjeDymond, Angela W., et al. "Effects of Cytochrome P450 (CYP3A4 and CYP2C19) Inhibition and Induction On the Exposure of Selumetinib, a MEK1/2 Inhibitor, in Healthy Subjects: Results From Two Clinical Trials." Eur J Clin Pharmacol 2016.